Category Archives: News

Bulgaria Pharmaceuticals and Healthcare Report Q1 2012 Business Monitor International’s Bulgaria Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Bulgaria’s pharmaceuticals and healthcare … Continue reading →

Diplomat Specialty Pharmacy to Provide Specialty Pharmacy Services for EYLEA™ (aflibercept) Injection Diplomat Specialty Pharmacy, the nation’s largest independent specialty pharmacy in the nation, announced today it has received limited distribution rights from Regeneron for its new drug EYLEA™ (aflibercept) … Continue reading →

Apeiron, GSK begin phase IIa trial in Acute Lung Injury patients Apeiron Biologics announced that GlaxoSmithKline (GSK), that has licensed Apeiron´s new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has commenced a phase IIa study … Continue reading →

Cantor Fitzgerald Analysts Reiterate a “Buy” Rating on Salix Pharmaceuticals (SLXP) Salix Pharmaceuticals (NASDAQ: SLXP)‘s stock had its “buy” rating reaffirmed by equities research analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday. Separately, analysts at … Continue reading →

Impax Pharmaceuticals Initiates Phase IIb Trial of IPX159 in Restless Legs Syndrome Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. IPXL +0.11% , announced that it has initiated a Phase IIb trial of its drug candidate IPX159 in … Continue reading →

PMSI report sees reversal of three-year trend on pharmacy spend The company’s 2011 Annual Drug Trends Report shows decreases in pharmacy costs and utilization based on an analysis of 5.4 million retail and mail-order transactions between 2008 and 2010. The … Continue reading →

Glenmark Gets Licensing Deal Boost Glenmark Pharmaceuticals Ltd. stock got a booster Monday after the company said it has agreed to license out development and commercialization rights of a biologic treatment to France’s Sanofi-Aventis S.A. Shares in the company zoomed … Continue reading →

FDA Approves Merck’s New Drug Victrelis For Treatment Of Hepatitis C The U.S. Food and Drug Administration (FDA) announced late yesterday that it has approved Victrelis for the treatment of hepatitis C. Victrelis (boceprevir), which will be marketed by the … Continue reading →

Takeda says has not agreed to buy Nycomed Takeda, Japan’s largest drugmaker, said on Friday it has not agreed to buy Swiss rival Nycomed, following reports it was in talks to buy the privately held company for more than $12 … Continue reading →

Aurobindo turns billion dollar pharmaceutical company Hyderabad-based Aurobindo Pharma has joined the billion-dollar club of pharma fraternity as the company’s consolidated revenues registered a growth of 22.5% at Rs 4381.5 crore in the financial year ended March 31, 2011 as … Continue reading →